Table of Contents

FDA EFOIA Reading Room

Documents in PDF format require the use of Adobe Acrobat Reader.

How to submit a FOI Request:  Handbook for Requesting Information and Records From FDA

Final Opinions

• Departmental Appeals Board Decisions

Policy Statements

• HHS Policy for Records Management
• HHS Policy for Improving Race and Ethnicity Data
• CVM Guidance Documents

Administrative Staff Manuals

• HHS Administrative Manuals
• CVM Program Policy and Procedures Manual
• CVM Compliance Policy Guides

Frequently Requested Records

Product Approval Information

• NADA/ANADA FOI Summaries
• Listing of Veterinary Master Files
• Environmental Assessments, Findings of No Significant Impact, and Environmental Impact Statements
• Currently Approved Labels for Companion Animal NSAIDs

Compliance & Enforcement

• Warning Letters 
• CVM's Notice of Regulatory Activity Letters to Pharmaceutical Companies
• Listing of Approved Medicated Feed Mill Licenses
• CVM and Ruminant Feed (BSE) Inspections
• CVM Letter to Feed and Feed Ingredient Manufacturers, May 16, 2007
• Diamond Pet Food Processors, Gaston, SC, FDA 483 Inspectional Observations, dated 12/21/2005 - 01/19/2006 (pdf size 110 KB)
• Correspondence to veal implant sponsors regarding label warnings, April 28, 2004
  • Ivy Animal Health
  • Fort Dodge Animal Health
  • Intervet, Inc.
  • Schering-Plough Animal Health Cor

Safety & Health

• Cumulative Veterinary Adverse Drug Experience (ADE) Reports
• FDA/CVM Report on the Risk from Pentobarbital in Dog Food | doc | | pdf |
  CVM’s researchers have concluded that the low levels of exposure to pentobarbital that dogs might receive through pet food is unlikely to cause them any adverse health effects.
  
  Miscellaneous

• Veterinary Medicine Advisory Committee
• FDA Response to Citizen Petition, dated March 9, 1999, submitted by the Center for Science in the Public Interest, Docket # 99P-0485, re:  subtherapeutic uses of antibiotics in livestock feed
• FDA Response to Citizen Petition, dated October 21, 1999, Submitted by Robert Cohen, Docket # 99P-4613, re:  Posilac® (recombinant bovine growth hormone product)

Obtaining Information From Other FDA Sources:

• Certain materials about CVM-related matters that were prepared for public distribution (e.g., press releases, consumer publications, speeches, congressional testimony) are available from both the FDA Internet site and the FDA Electronic Freedom of Information Reading Room.

CVM A-Z Index | Contact CVM | About CVM | Site Map
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page